Pillai K, Misra S, Siripurapu G, Aliyar A, Bhat P, Rajan R
Ann Indian Acad Neurol. 2023; 26(5):702-707.
PMID: 38022478
PMC: 10666879.
DOI: 10.4103/aian.aian_572_23.
Fung W, Fasano A, Fearon C
Mov Disord Clin Pract. 2023; 10(Suppl 2):S9-S17.
PMID: 37637980
PMC: 10448146.
DOI: 10.1002/mdc3.13615.
Schneider S, Desai S, Phokaewvarangkul O, Rosca E, Sringean J, Anand P
J Neurol. 2023; 270(5):2409-2415.
PMID: 36943516
PMC: 10029788.
DOI: 10.1007/s00415-023-11661-x.
Godani M, Beronio A, Lanza G
Mov Disord Clin Pract. 2022; 9(Suppl 2):S6-S8.
PMID: 36118515
PMC: 9464991.
DOI: 10.1002/mdc3.13534.
Gentile F, Bocci T, Coppola S, Pozzi T, Modafferi L, Priori A
Biomedicines. 2022; 10(3).
PMID: 35327531
PMC: 8944980.
DOI: 10.3390/biomedicines10030729.
Movement Disorders Associated with COVID-19.
Salari M, Zaker Harofteh B, Etemadifar M, Sedaghat N, Nouri H
Parkinsons Dis. 2021; 2021:3227753.
PMID: 34790346
PMC: 8592762.
DOI: 10.1155/2021/3227753.
New-Onset Movement Disorders Associated with COVID-19.
Brandao P, Grippe T, Pereira D, Munhoz R, Cardoso F
Tremor Other Hyperkinet Mov (N Y). 2021; 11:26.
PMID: 34277139
PMC: 8269765.
DOI: 10.5334/tohm.595.
De Novo Movement Disorders and COVID-19: Exploring the Interface.
Ghosh R, Biswas U, Roy D, Pandit A, Lahiri D, Ray B
Mov Disord Clin Pract. 2021; 8(5):669-680.
PMID: 34230886
PMC: 8250792.
DOI: 10.1002/mdc3.13224.
Neurological manifestations and neuroimaging findings in patients with SARS-CoV2-a systematic review.
Mohan N, Fayyaz M, Del Rio C, Khurana N, Vaidya S, Salazar E
Egypt J Neurol Psychiatr Neurosurg. 2021; 57(1):68.
PMID: 34093004
PMC: 8170868.
DOI: 10.1186/s41983-021-00322-3.
Myoclonus-Ataxia Syndrome Associated with COVID-19.
Shetty K, Jadhav A, Jayanthakumar R, Jamwal S, Shanubhogue T, Reddy M
J Mov Disord. 2021; 14(2):153-156.
PMID: 33819422
PMC: 8175811.
DOI: 10.14802/jmd.20106.
Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.
Pensato U, Muccioli L, Cani I, Janigro D, Zinzani P, Guarino M
Ann Clin Transl Neurol. 2021; 8(4):968-979.
PMID: 33780166
PMC: 8045903.
DOI: 10.1002/acn3.51348.
Isolated generalized myoclonus immune-mediated by SARS-CoV-2: an illustrative videotaped case.
El Otmani H, Moutaouakil F, Ouazzani M, Mjahed K
Neurol Sci. 2021; 42(8):3411-3413.
PMID: 33718991
PMC: 7956434.
DOI: 10.1007/s10072-021-05164-8.
COVID-19-Associated Neurological Manifestations: An Emerging Electroencephalographic Literature.
Vellieux G, Sonneville R, Vledouts S, Jaquet P, Rouvel-Tallec A, dOrtho M
Front Physiol. 2021; 11:622466.
PMID: 33679425
PMC: 7933549.
DOI: 10.3389/fphys.2020.622466.
Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.
Chan J, Murphy K, Sarna J
J Neurol. 2021; 268(10):3517-3548.
PMID: 33616739
PMC: 7897737.
DOI: 10.1007/s00415-021-10458-0.
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms.
Blanco-Palmero V, Azcarate-Diaz F, Ruiz-Ortiz M, Laespada-Garcia M, Rabano-Suarez P, Mendez-Guerrero A
J Neurol. 2021; 268(9):3116-3124.
PMID: 33606070
PMC: 7892700.
DOI: 10.1007/s00415-021-10444-6.
Myoclonus and COVID-19: A Challenge for the Present, a Lesson for the Future.
Latorre A, Rothwell J
Mov Disord Clin Pract. 2020; 7(8):888-890.
PMID: 33163558
PMC: 7604694.
DOI: 10.1002/mdc3.13103.
